Furthermore, the Nur77 agonists, ATE-i2-b4 [9], H-9 [9], Cns-B [25] and its analogue Cns-A [26], suppressed both in vitro and in vivo growth of cancer cells through inducing cytoplasmic expression of Nur77 and its nuclear export [9]. This evidence concerns the gene NR4A1 and cancer.